Pfizer in talks to launch consumer ED product
This article was originally published in The Tan Sheet
Executive SummaryUndeterred by challenges to switching Viagra (sildenafil), Pfizer is reportedly developing a new Viagra-like erectile dysfunction product in the U.K. that it hopes to sell directly to consumers, according to 1Campaign, an advertising industry publication. A Pfizer spokeswoman would not confirm the potential launch, but noted in an e-mail that the firm "routinely evaluates" drug delivery and formulations. The New York-based firm withdrew its centralized switch application in the EU for Viagra November 2008 for further evaluation after regulators expressed health safety concerns (2"The Tan Sheet" Nov. 24, 2009). Health concerns include negative interactions with nitrates for blood pressure. According to Campaign, Pfizer wants to launch the product in 2011. It reports the product includes the same ingredient as Viagra, but is modified slightly. U.K. pharmacy chain Alliance Boots already sells Rx Viagra without a prescription through pharmacists at 29 stores under the country's Quality Care Commission regulations. A pilot Boots launched in 2007 showed pharmacists effectively could determine whether customers should use Viagra and that the program would prevent abuse by consumers trying to buy the drug for recreational purposes, the chain said in June 2009. Customers must register for the service with Boots and agree to have their doctors notified that they are buying Viagra (3"The Tan Sheet" June 29, 2009)
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.